Cardiovascular diseases remain a global challenge, and lipid-associated biomarkers can
predict cardiovascular events. Extensive research on cardiovascular benefits of omega-3 …

Objectives To the best of our knowledge, no systematic review and meta-analysis has
evaluated the cholesterol-lowering effects of intermittent fasting (IF) and energy-restricted …

Objectives Emerging studies have employed time-restricted feeding (TRF) and a low-sugar
diet alone in the management of non-alcoholic fatty liver disease (NAFLD), but their …

Background and aim The exact effect of vitamin D administration on the lipid profile in
postmenopausal women is unknown. However, as dyslipidemia is a recognized risk factor …

Background and aims Dietary regimens are crucial in the management of non-alcoholic fatty
liver disease (NAFLD). The effects of intermittent fasting (IF) have gained attention in this …

Lipoprotein (a)[Lp (a)] is an independent, causal, genetically determined risk factor for
cardiovascular disease (CVD). We provide an overview of current knowledge on Lp (a) and …

Breakfast consumption is generally considered a health‐promoting habit for
cardiometabolism, particularly with regard to chrononutrition. Glucose uptake is enhanced …

Omega-3 polyunsaturated fatty acids (n-3 PUFA) play a significant role in the prevention and
management of cardiometabolic diseases associated with a mild chronic pro-inflammatory …

Apolipoprotein (a)(apo (a)) is the protein component that defines lipoprotein (a)(Lp (a))
particles and is encoded by the LPA gene. The apo (a) is extremely heterogeneous in size …

Background & aims The relationship between obesity, weight loss, and high-density
lipoprotein cholesterol (HDL-C) is poorly recognized and understood. Methods Through an …